genocea.comGenocea

-- About Platform Platform Presentations and Publications Pipeline Investors ns Contact About Platform Platform Presentations and Publications Pipeline Investors ns Contact Pioneering neoantigen immunotherapies As individual as the cancers we target ’s mission is to help conquer cancer through targeted vaccines and immunotherapies. Using our revolutionary ATLAS™ platform to identify true T cell antigens, we are creating new lifelines for cancer patients by listening to and learning from the immune system. LATEST NEWS Featured May 11, 2020 May 11, 2020 REMINDER: to Host KOL Symposium Highlighting GEN-011’s Potential to Transform T cell Therapy for Solid Tumors May 11, 2020 May 5, 2020 May 5, 2020 to Host KOL Symposium Highlighting GEN-011’s Potential to Transform T cell Therapy for Solid Tumors May 5, 2020 MORE THE GENOCEA DIFFERENCE At , we believe that targets matter, and we are advancing a growing pipeline of innovative cancer therapies that demonstrate that target – or antigen – selection plays an important role in driving immunotherapy efficacy. MORE BECOME A GENOCEAN ns make waves. We seek new colleagues who are dedicated to our mission and who will thrive in a dynamic, driven, and results-oriented environment. MORE ABOUT Corporate Overview Management Team Board of Directors Scientific Advisory Board PLATFORM ATLAS Platform Presentations and Publications P IPELINE GEN-009 Partnering With INVESTORS Overview Press Releases Events & Presentations Corporate Governance Financial Filings Stock Information GENOCEANS Mission Statement Core Values ns at Work ns at Play Become a n CONTACT 100 Acorn Park Dr Cambridge, MA 02140 Phone: 617.876.8191 Fax: 617.500.0969 CONNECT WITH US TERMS OF USE Back to Top Biosciences, Inc. Copyright © 2020...